Mifepristone (RU 486) registered for use in Australia

Parliament house flag post

Mifepristone (RU 486) registered for use in Australia

Posted 31/08/2012 by Amanda Biggs


The Therapeutic Goods Administration (TGA), the regulator of medicines and therapeutic devices in Australia, has announced that from 29 August 2012 the abortifacient mifepristone (RU 486) will be listed on the Australian Register of Therapeutic Goods (ARTG). Misoprostol, a drug that can be used in conjunction with mifepristone but already available in Australia, has also been approved for use in medical abortion. Medical abortion is a method of pregnancy termination that involves the administration of a drug or drugs to induce an abortion, and is distinct from surgical abortion.



The approval of mifepristone follows the successful application by Marie Stopes International Australia (Marie Stopes), a national provider of sexual health and family planning services, to have it registered for pregnancy termination. Registration on the ARTG means that mifepristone is now allowed to be marketed and sold in Australia, although potential prescribers must still abide by the laws on abortion in their jurisdiction.

Since 2006, when a Ministerial veto on its use in Australia was lifted (for background, see this Parliamentary library publication), mifepristone has only been available through the TGA’s Authorised Prescriber Scheme. Under the Authorised Prescriber Scheme a medical practitioner who wants to prescribe mifepristone must apply to the TGA for permission to import the drug and is required to administer it under strict conditions and with ethical oversight.

Prior to 2006, mifepristone was classified as a ‘restricted good’ which could only be imported into Australia with written Ministerial approval. While not a direct ban, this restriction effectively discouraged potential sponsors from seeking approval, as it ensured any application to import the drug would attract considerable political attention. With the passage of the Therapeutic Goods Amendment (Repeal of Ministerial responsibility for approval of RU486) Bill 2005 (see the Bills Digest for details), the Ministerial authority to approve the importation of mifepristone was removed. This meant that in line with other drug approvals it was the responsibility of the TGA to assess the efficacy, safety and quality of mifepristone if any application for registration was made.

However, at the time Ministerial authority was removed no sponsor undertook to apply for registration of mifepristone, so it remained accessible only through the Authorised Prescriber Scheme. It has been suggested that the small size of the Australian market, the political history surrounding the drug and Australia’s abortion laws have contributed to sponsor reluctance. As of August 2012, 187 medical practitioners had obtained authorisation to prescribe mifepristone for pregnancy termination. Listing on the ARTG according to the TGA statement, means that medical termination will now be available to a wider group of Australian women.

Mifepristone has been approved for use in a number of countries, including the United Kingdom, the United States, much of Western Europe, Russia, China, Israel, New Zealand, Turkey and Tunisia. It works by blocking the effects of the hormone progesterone, which is crucial to starting and maintaining pregnancy. The prostaglandin misoprostol is then administered, which induces uterine contractions and results in the expulsion of the contents of the uterus. Mifepristone is mainly administered in the first trimester of pregnancy; the TGA has approved its use in the first 7 weeks of pregnancy.

While termination using mifepristone is generally regarded as being a safe procedure, the death of an Australian woman from sepsis in 2010 who was prescribed the drug did raise some questions over patient care. Data from South Australia, which is one of the few jurisdictions that mandates reporting of abortion statistics, reports the complication rate for the 669 mifepristone/misoprostol induced terminations undertaken in 2010, was 5.2 per cent (mainly due to the contents of the uterus being retained). This rate of complication was higher than for surgical abortion (0.5 per cent), but lower than for other medical methods (administration of other prostaglandins orally or vaginally). According to the TGA statement, since going onto the Authorised Provider Scheme, 792 reports of adverse events associated with mifepristone have been provided to the TGA (and one recorded death due to sepsis).

As the sponsor, Marie Stopes has undertaken to include a tailored educational package for medical practitioners who seek to prescribe mifepristone. Only those medical practitioners who have completed appropriate training as approved by Marie Stopes will be able to prescribe and administer the drug (although Fellows and Diploma holders of the Royal Australian and New Zealand College of Obstetricians and Gyneacologists will not have to complete the training). Supply of mifepristone will also be provided through Marie Stopes. The registration of mifepristone is also conditional upon the sponsor undertaking a post marketing study that must include the reporting of any serious adverse events associated with mifepristone such as retained products, bleeding and infection.

Listing on the ARTG does not mean the drug automatically goes onto the subsidised medicine list, the Pharmaceutical Benefits Scheme (PBS). A separate application for listing must be made to the independent evaluator, the Pharmaceutical Benefits Advisory Committee. News media have reported that Marie Stopes is considering applying for a PBS listing.

The listing of mifepristone is likely to remain controversial, given its past history in Australia and the ongoing opposition to abortion among a proportion of the Australian population. Reports of any adverse events associated with its wider availability will be scrutinised, as will the role of the TGA in overseeing its safety and efficacy. Whether it’s listing on the ARTG will have broader impacts, including on the legal status of abortion in the states and territories, may depend on it establishing a record of safety and efficacy.


Thank you for your comment. If it does not require moderation, it will appear shortly.

Add your comment

[Click to expand]

We welcome your comments, or additional information which is relevant to a post. These can be added by clicking on the ‘Add your comment’ option above. Please note that the Parliamentary Library will moderate comments, and reserves the right not to publish comments that are inconsistent with the objectives of FlagPost. This includes comments that are not relevant to the article, factually incorrect or politically partisan, as well as spam, profanity and personal abuse. We will close comments after three months.




Captcha
Generate a new image
Type characters from the image:

Facebook LinkedIn Twitter Add | Email Print

FlagPost

Flagpost is a blog on current issues of interest to members of the Australian Parliament


Parliamentary Library Logo showing Information Analysis & Advice

Archive

Syndication

Tagcloud

refugees asylum immigration climate change Australian foreign policy parliament social security elections welfare reform welfare policy school education Australian Defence Force health financing higher education emissions trading indigenous Australians women private health insurance people trafficking Employment illicit drugs gambling health reform federal election 2010 Middle East disability Sport Australian Bureau of Statistics statistics United Nations Asia Afghanistan income management Medicare health forced labour Taxation Australian Sports Anti-Doping Agency World Anti-Doping Agency United States federal budget Industrial Relations Carbon Pricing Mechanism politics dental health Australian Electoral Commission WADA criminal law transport aid child protection environment poker machines Australia in the Asian Century steroids National Disability Insurance Scheme detention aged care 43rd Parliament slavery health system ASADA Law Enforcement Australian Federal Police Fair Work Act Australian Public Service governance labour force people smuggling debt international relations constitution New Zealand food Australian Crime Commission pharmaceutical benefits scheme OECD corruption pensions public service reform children's health Aviation federal election 2013 foreign debt gross debt net debt defence capability parliamentary procedure Senate Senators and Members ALP Newstart Parenting Payment multiculturalism Youth Allowance sea farers UK Parliament election results voting mental health Federal Court terrorist groups science social media Higher Education Loan Program HECS federal state relations accountability Papua New Guinea youth paid parental leave same sex relationships coal seam gas customs planning doping crime health risks International Women's Day Gonski Review of Funding for Schooling sex slavery Special Rapporteur Northern Territory Emergency Response social policy violence against women domestic violence China ADRV terrorism transparency research and development welfare ASIO intelligence community Australian Security Intelligence Organisation carbon tax mining High Court military history electoral reform employer employee renewable energy regional unemployment fishing by-election European Union family assistance skilled migration banking United Nations Security Council Australian economy forestry food labelling vocational education and training Drugs welfare systems Indonesia children Constitutional reform local government codes of conduct terrorist financing homelessness Parliamentary remuneration money laundering Trafficking in Persons Report energy social inclusion human rights paternalism national security fuel disability employment Tasmania integrity standards NATO Australian Secret Intelligence Service sexual abuse World Trade Organization Australia public health housing affordability bulk billing political parties water productivity health policy Governor-General US economy trade unions export liquefied natural gas foreign bribery firearms question time speaker superannuation public housing expertise public policy climate Intergovernmental Panel on Climate Change leadership Department of Agriculture Fisheries and Forestry regulation Pacific Islands reserved seats new psychoactive substances synthetic drugs UNODC carbon markets animal health middle class welfare Census Indigenous constitutional recognition of local government referendum consumer laws PISA competition policy royal commission US politics language education baby bonus Leaders of the Opposition citizen engagement policymaking Australia Greens servitude Trafficking Protocol forced marriage Population rural and regional alcohol entitlements ministries Hung Parliament social citizenship maritime Iran ANZUS regional students school chaplains federal budget 2011-12 salary Medicare Locals primary care Building the Education Revolution EU China soft power education Fiji India Disability Support Pension Antarctica Diplomacy by-elections state and territories Bills anti-corruption fraud bribery corporate ownership whistleblower G20 economic reform innovation Members of Parliament Scottish referendum early childhood education Middle East; national security; terrorism social services Criminal Code Amendment (Misrepresentation of Age to a Minor) Bill 2013 online grooming sexual assault of minors ACT Assembly smoking plain packaging tobacco cigarettes Asia; Japan; international relations Work Health and Safety Migration; asylum seekers; regional processing China; United States; international relations fiscal policy Racial Discrimination Act; social policy; human rights; indigenous Australians Foreign policy Southeast Asia Israel Palestine asylum refugees immigration political finance donations foreign aid Economics efficiency human rights; Racial Discrimination Act employment law bullying asylum seekers Animal law; food copyright Australian Law Reform Commission industry peace keeping contracts workplace policies same-sex marriage disorderly conduct retirement Parliament House standing orders prime ministers election timetable sitting days First speech defence budget submarines workers financial sector Canada Somalia United Kingdom GDP world heritage political engagement leave loading Trade; tariffs; safeguards; Anti-dumping public interest disclosure whistleblowing Productivity Commission limitation period universities Ireland cancer gene patents genetic testing suspension of standing and sessional orders live exports infant mortality honorary citizen railways disciplinary tribunals standard of proof World Health Organisation arts international students skilled graduate visas temporary employment visas apologies roads Italy national heritage NHMRC nutrition anti-dumping Rent Assistance obesity evidence law sacrament of confession US presidential election international days DFAT UN General Assembly deregulation Regulation Impact Statements administrative law small business Breaker Morant regional engagement social determinants of health abortion Members suspension workplace health and safety marine reserves hearing TAFE Victoria astronomy resources sector YMCA youth parliament Korea rebate Australian Greens presidential nomination Racial Discrimination Act political parties preselection solar hot water Financial Action Taskforce Horn of Africa peacekeeping piracy Great Barrier Reef Stronger futures political financing political education Social Inclusion Board early childhood National Quality Framework for Early Childhood Education and Care Murray-Darling Basin sanctions Norway hospitals republic President Barack Obama Presidential visits qantas counselling Korean peninsula Work Choices biosecurity hendra environmental law federalism federation preselection therapeutic goods Therapeutic Goods Administration plebiscites computer games pests suicide nuclear COAG Ministerial Councils floods ADHD stimulant medication advertising electricity extradition conscience votes poverty preventative health rural health coastal erosion Parliamentary Budget Office work-life balance

Show all
Show less
Back to top